Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
暂无分享,去创建一个
[1] D. Donnell,et al. Twenty‐eight‐day Double‐blind Safety Study of an HFA‐134a Inhalation Aerosol System in Healthy Subjects , 1996, The Journal of pharmacy and pharmacology.
[2] J. Ayres,et al. Incidence of acute decreases in peak expiratory flow following the use of metered-dose inhalers in asthmatic patients. , 1994, The European respiratory journal.
[3] Wan Ariffin Bin Abdullah. Singapore Med J , 1993 .
[4] Buist As. Standardization of spirometry. , 1987 .
[5] M. H. Williams,et al. Cough and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide. , 1987, Annals of internal medicine.
[6] M. H. Williams,et al. Cough and wheezing from beclomethasone aerosol. , 1987, Chest.
[7] R. J. Clark. EXACERBATION OF ASTHMA AFTER NEBULISED BECLOMETHASONE DIPROPRIONATE , 1986, The Lancet.
[8] W. Yt,et al. Severe bronchoconstriction after inhalation of beclomethasone and budesonide. , 1986 .
[9] Deep-inspiration induced bronchoconstriction: a mechanism for beclomethasone aerosol intolerance. , 1983, European journal of respiratory diseases.
[10] J. Malo,et al. Acute bronchoconstriction caused by Beclovent and not Vanceril , 1979, Clinical allergy.
[11] J. Pepys,et al. Bronchial reactions to aerosol inhalant vehicle. , 1976, British medical journal.